Edition:
India

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

11.19CNY
19 Apr 2019
Change (% chg)

¥-0.08 (-0.71%)
Prev Close
¥11.27
Open
¥11.21
Day's High
¥11.33
Day's Low
¥11.13
Volume
67,003,346
Avg. Vol
139,132,782
52-wk High
¥28.25
52-wk Low
¥5.75

Latest Key Developments (Source: Significant Developments)

China Chengxin Securities Rating Downgrades Kangmei Pharma's Long-Term Credit Rating
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS CHINA CHENGXIN SECURITIES RATING HAS DOWNGRADED ITS LONG-TERM CREDIT RATING TO AA+ FROM AAA.  Full Article

Kangmei Pharmaceutical Says 9-Month Net Profit Up 22.1 Percent Y/Y
Friday, 26 Oct 2018 

Oct 26 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS 9-MONTH NET PROFIT UP 22.1 PERCENT Y/Y.  Full Article

Shanghai Exchange Filing Shows Block Trade Of Kangmei Pharmaceutical's Shares Involving 152 Mln Yuan
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Shanghai Stock Exchange ::FILING SHOWS BLOCK TRADE OF KANGMEI PHARMACEUTICAL CO LTD'S <<<600518.SS>>> 7.47 MILLION SHARES INVOLVING 152 MILLION YUAN ($22.13 million) ON SEPT 17.  Full Article

Shanghai Exchange Filing Shows Block Trade Of Kangmei Pharma's Shares Involving 555.1 Mln Yuan
Monday, 11 Jun 2018 

June 11 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SHANGHAI STOCK EXCHANGE FILING SHOWS BLOCK TRADE OF KANGMEI PHARMACEUTICAL'S 25.0 MILLION SHARES INVOLVING 555.1 MILLION YUAN ($86.69 million) ON JUNE 11.  Full Article

Kangmei Pharmaceutical Says Q1 Net Profit Up 33.3 Percent Y/Y
Friday, 27 Apr 2018 

April 27 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS Q1 NET PROFIT UP 33.3 PERCENT Y/Y.  Full Article

Kangmei Pharmaceutical to pay annual cash div as 2.35 yuan per 10 shares for FY 2017
Thursday, 26 Apr 2018 

April 26(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> : :* Says it plans to pay annual cash dividend as 2.35 yuan(pre-tax) per 10 shares as FY 2017 div payment.  Full Article

Kangmei Pharmaceutical's 2017 Net Profit Up 22.8 Pct Y/Y At 4.1 Bln Yuan
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>::SAYS 2017 NET PROFIT UP 22.8 PERCENT Y/Y AT 4.1 BILLION YUAN ($648.71 million).  Full Article

Kangmei Pharmaceutical issues 2018 second tranche mid-term bills worth 1 bln yuan
Monday, 2 Apr 2018 

April 2(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS>:Says it issued 2018 second tranche mid-term bills worth 1 billion yuan, with term of three years and coupon rate of 6.1 percent .  Full Article

Kangmei Pharmaceutical issues 2018 1st tranche mid-term bills worth 1 bln yuan
Thursday, 22 Mar 2018 

March 22(Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says it issued 2018 1st tranche 3-year mid-term bills worth 1 billion yuan, with coupon rate of 6.28 percent .  Full Article

Kangmei Pharmaceutical unit to buy 80 pct stake in Fuzhou-based pharma equipment firm
Tuesday, 20 Mar 2018 

March 20 (Reuters) - Kangmei Pharmaceutical Co Ltd <600518.SS> ::Says its wholly owned unit plans to buy 80 percent stake in a Fuzhou-based pharma equipment firm .Transaction price is 6.7 million yuan .  Full Article